FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Resverlogix Corp. Stock AnalysisComprehensive stock analysis for Resverlogix Corp. (RVXCF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRVXCF
RVXCF
Resverlogix Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RVXCF
Home🔹Stocks🔹Resverlogix Corp.

Resverlogix Corp.

RVXCF•OTC

Resverlogix Corp.

RVXCF•OTC
Market cap
$22.99M
Sentiment

Your view on RVXCF

Mkt Cap
$22.99M
Sentiment
Your view
RVXCF
Resverlogix Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RVXCF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Resverlogix Corp.

Industry
Biotechnology
Sector
Healthcare
CEO
Donald J. McCaffrey
Headquarters
4820 Richard Road SW, Calgary, AB, CA
Industry
Biotechnology
Sector
Healthcare
CEO
Donald J. McCaffrey
Headquarters
4820 Richard Road SW, Calgary, AB, CA
Description

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News